Skip to main content

Life Sciences is now live. See how →

Patent work, perfected by AI.Secure. Accurate.

Draft applications, respond to office actions, and search prior art in one secure workspace built for patent work.

An agent and a canvas. One secure workspace.

An AI agent works alongside you and every capability opens on one canvas, from drafting and figures to prior art and office action responses, all tied to your matter. Create projects so context is never lost, collaborate with colleagues on the same matter, and standardize firm workflows with a shared prompt library.

Boundly AI Studio
ClaudeClaudeGPTGPTGeminiGeminiGrokGrok
Claude agent

Do a prior art search.

Searching 96M+ patents, indexed NPL, and the FDA Orange and Purple Book.

Prior Art
US 9,182,345 B294%
EP 3 145 678 A189%
WO 2019/123456 A186%
J. Membrane Sci. (2018)81%
Orange Book NDA 021-55378%

Built for Real Patent Practice

Turn invention disclosures into claims with strategic depth, and draft the figures and specification in the same workspace.
Draft office action responses with the examiner’s and art unit’s prosecution history in view
NewDraft Markush and antibody claims from your compounds and sequences with Life Sciences
Simulate rejections and populate IDS forms
Run prior-art search across 96M+ patents, indexed NPL, plus the FDA Orange Book and Purple Book
Work across USPTO, WIPO, EPO, JPO, CNIPA, KIPO, ILPO and more with inline localization in 15+ languages

New in AI Studio

Compounds and sequences, drafted as claims.

Life Sciences brings chemistry and biology into AI Studio. Genus and antibody claims are derived directly from your structures and sequences, not written by a model. Where an answer depends on judgment rather than structure, Boundly says so instead of guessing.

Chemistry

ChemDraw · SDF · SMILES · SAR spreadsheet

R1R2R3Formula (I)
R-group table for Formula (I)
PosValues
R1H, F, Cl, Me
R2OMe, OCF3
R3CN, CH(OH)Me
  1. 1.A compound of Formula (I), or a pharmaceutically acceptable salt thereof.
  2. 6.The compound of claim 1, wherein R1 is F or Cl.
  3. 12.A compound selected from the group consisting of the following compounds:FOMeNCMeOMeNCSpecies claims as fallbacks below the genus, each compound drawn as its structure.
Compound 9 flagged. Undefined stereocenter.

Biology

FASTA · GenBank · IMGT / Kabat / Chothia / AbM

  • HCDR1SEQ ID NO: 1
  • HCDR2SEQ ID NO: 2
  • HCDR3SEQ ID NO: 3
  • LCDR1SEQ ID NO: 4
  • LCDR2SEQ ID NO: 5
  • LCDR3SEQ ID NO: 6

1. An antibody comprising a heavy chain variable region comprising HCDR1, HCDR2, and HCDR3 comprising the amino acid sequences of SEQ ID NOs: 1, 2, and 3, respectively, and a light chain variable region comprising LCDR1, LCDR2, and LCDR3 comprising the amino acid sequences of SEQ ID NOs: 4, 5, and 6, respectively.

ST.26 listing validated by Boundly before export.

Illustrative example. Simplified structures chosen to show the claim format, not a patentable series or a real antibody.

It also tests a compound against a genus, checks a genus against compounds from the cited art, and keeps every reference in step when you reorder sequences.

Catch §112 rejections before the examiner does.

Pre-filing §101, §102, and §103 checks coming soon

Tired of waiting months for examiner feedback? Upload your patent application and get detailed rejection reports (with citations and fix suggestions) in minutes, not months.

Boundly Rejection Simulator

Detection Rate Comparison

Boundly0%
Base LLMs0%

Benchmarked on real USPTO §112 rejections. Boundly catches 2× more issues than base language models.

Foreign filings that start in the right form.

Translate and restructure patents to match each office's drafting conventions.

USPTO source
1. An electric toothbrush, comprising:
a handle;
a brush head coupled to the handle;
a pressure sensor disposed within
the handle and configured to
detect a brushing force; and
a haptic feedback unit configured
to vibrate the handle when the
brushing force exceeds a threshold.
EPO, two-part form
 
 
 
 
 
 
 
 
 
 

Built for cross-jurisdiction filings

Translate or Localize

Language-only translation or full structural localization, pick per filing.

Every major jurisdiction

USPTO, EPO, JPO, CNIPA, KIPO, and more, plus PCT national phase. 15+ languages.

Review-ready output

A structurally localized draft with a diff against your source, ready to hand to local counsel.

Frequently asked questions.

Does Boundly write the entire patent for me?
No. Boundly is an assistive tool. It accelerates drafting, illustration, prior art, and prosecution work, but every output requires your professional review. Final responsibility for filings and decisions rests with the user and their qualified counsel.
Which AI models can I use in AI Studio?
Claude, GPT, Gemini, and Grok, all from one interface. You can switch between them anytime and compare answers side by side. They run on enterprise model endpoints, not consumer AI.
Can AI Studio help me respond to an office action using my examiner’s history?
Yes. The office action response workflow in AI Studio shows how your examiner and art unit have handled rejections like yours and which arguments and amendments moved them. You draft the response with tracked changes and stay the author.
Does Boundly support chemistry and biology patent work?
Yes. Life Sciences is part of AI Studio. Draft Markush and species claims from your compounds, and sequence and antibody claims with an ST.26 listing from your sequences.
Can I use Boundly for international patents?
Yes. Patent Localizer translates and localizes filings for USPTO, EPO, JPO, CNIPA, and KIPO. AI Studio workflows run across the same jurisdictions. Examiner and art unit history and file wrappers are available for USPTO applications.
Do you train AI models on my data?
No. Your prompts, documents, and generated content are never used to train any model, including third-party models we route to. This is enforced at the contract level with every model provider and documented in your DPA.
Is there a free trial?
Yes. Standard plans include a 7-day free trial. Enterprise customers may have access to extended trials.

See all questions →